Showing 1 - 4 results of 4 for search 'Yanmeng Chen' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Yanmeng Chen
Showing 1 - 4 results of 4 for search 'Yanmeng Chen', query time: 0.03s Refine Results
  1. 1
    Performance of passive design strategies in hot and humid regions. Case study: Tangerang, Indonesia

    Performance of passive design strategies in hot and humid regions. Case study: Tangerang, Indonesia by Yanmeng Chen, Masayuki Mae, Keiichiro Taniguchi, Teruki Kojima, Hiroshi Mori, Andhang Rakhmat Trihamdani, Kohei Morita, Yukie Sasajima

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.

    Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma. by Xuan Luo, Yao Huang, Yanmeng Chen, Zeng Tu, Jieli Hu, John E Tavis, Ailong Huang, Yuan Hu

    Published 2016-01-01
    Get full text
    Article
  3. 3
    DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B

    DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B by Yanmeng Chen, Bocun Shen, Xiaochuan Zheng, Quanxin Long, Jie Xia, Yao Huang, Xuefei Cai, Deqiang Wang, Juan Chen, Ni Tang, Ailong Huang, Yuan Hu

    Published 2020-01-01
    Get full text
    Article
  4. 4
    Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia

    Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia by Jun Ren, Junpeng Huang, Zailin Yang, Minghui Sun, Jing Yang, Can Lin, Fangfang Jin, Yongcan Liu, Lisha Tang, Jiayuan Hu, Xingyu Wei, Xinyi Chen, Zihao Yuan, Zesong Yang, Yanmeng Chen, Ling Zhang

    Published 2024-06-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs